Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00359710 · ClinicalTrials.gov registry record

Patients' Perspectives on Identity, Ancestry and Genetics

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
22
Enrollment target

NCT00359710: Completed study, sponsored by National Human Genome Research Institute (NHGRI).

NCT00359710 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00359710 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
22 participants
Enrollment target

Study Summary

This study will collect the opinions, understandings and personal health care experiences of multiracial persons of African and European ancestry. Understanding multiracial patients' beliefs and experiences about their race, ethnicity, ancestral origin and the genetic components of diseases can provide important data for developing ways to communicate how human genetic variation is related to self-identified race and ethnicity. The study will: * Investigate multiracial individuals' beliefs about biological and genetic differences based on race and ethnicity; * Collect stories of identity, ancestry and clinical experiences of multiracial individuals with one parent of African ancestry and one parent of European ancestry; * Investigate multiracial patients' experiences regarding family health history and communication of genetic risk of disease. Persons 21 years of age or older in the Atlanta, Georgia, or Washington, D.C., metropolitan areas who are from a multiracial background and have used health care services in the last 2 years may be eligible for this study. Participants are interviewed one-on-one for about 2 hours to gather information about their background, family ancestry, self-identity, race and ethnicity, health care interactions and genetics and health. Each participant completes a short questionnaire before and after the interview. ...

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2006-04-19
Est. Completion 2011-02-23

What the finished NCT00359710 record still lists

NCT00359710 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00359710 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00359710 about?

NCT00359710 is a clinical study titled "Patients' Perspectives on Identity, Ancestry and Genetics". This study will collect the opinions, understandings and personal health care experiences of multiracial persons of African and European ancestry. Understanding multiracial patients' beliefs and experiences about their race, ethnicity, ancestral origin and the genetic components of diseases can prov...

What is the current status of trial NCT00359710?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2006-04-19. Estimated completion is 2011-02-23.

Who is sponsoring clinical trial NCT00359710?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00359710, the US trial registry maintained by the National Library of Medicine. NCT00359710 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.